Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets

Thursday, September 21, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

- Provention to initiate Phase 2a Study of PRV-6527 (JNJ-40346527) in patients with moderate to severe Crohn's disease



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook